RT Journal Article SR Electronic T1 Obesity is associated with fatal coronary heart disease independently of traditional risk factors and deprivation JF Heart JO Heart FD BMJ Publishing Group Ltd and British Cardiovascular Society SP 564 OP 568 DO 10.1136/hrt.2010.211201 VO 97 IS 7 A1 Logue, Jennifer A1 Murray, Heather M A1 Welsh, Paul A1 Shepherd, James A1 Packard, Chris A1 Macfarlane, Peter A1 Cobbe, Stuart A1 Ford, Ian A1 Sattar, Naveed YR 2011 UL http://heart.bmj.com/content/97/7/564.abstract AB Background The effect of body mass index (BMI) on coronary heart disease (CHD) risk is attenuated when mediators of this risk (such as diabetes, hypertension and hyperlipidaemia) are accounted for. However, there is now evidence of a differential effect of risk factors on fatal and non-fatal CHD events, with markers of inflammation more strongly associated with fatal than non-fatal events.Objective To describe the association with BMI separately for both fatal and non-fatal CHD risk after accounting for classical risk factors and to assess any independent effects of obesity on CHD risk.Methods and results In the West of Scotland Coronary Prevention Study BMI in 6082 men (mean age 55 years) with hypercholesterolaemia, but no history of diabetes or CVD, was related to the risk of fatal and non-fatal CHD events. After excluding participants with any event in the first 2 years, 1027 non-fatal and 214 fatal CHD events occurred during 14.7 years of follow-up. A minimally adjusted model (age, sex, statin treatment) and a maximally adjusted model (including known CVD risk factors and deprivation) were compared, with BMI 25–27.4 kg/m2 as referent. The risk of non-fatal events was similar across all BMI categories in both models. The risk of fatal CHD events was increased in men with BMI 30.0–39.9 kg/m2 in both the minimally adjusted model (HR=1.75 (95% CI 1.12 to 2.74)) and the maximally adjusted model (HR=1.60 (95% CI 1.02 to 2.53)).Conclusions These hypothesis generating data suggest that obesity is associated with fatal, but not non-fatal, CHD after accounting for known cardiovascular risk factors and deprivation.Clinical trial registration WOSCOPS was carried out and completed before the requirement for clinical trial registration.